Leit í EES-gagnagrunni
COM(2021) 997
Directive (EU) 2022/642 of the European Parliament and of the Council of 12 April 2022 amending Directives 2001/20/EC and 2001/83/EC as regards derogations from certain obligations concerning certain medicinal products for human use made available in the United Kingdom in respect of Northern Ireland and in Cyprus, Ireland and Malta
D050582/03
Commission Directive (EU) 2017/1572 of 15 September 2017 supplementing Directive 2001/83/EC of the European Parliament and of the Council as regards the principles and guidelines of good manufacturing practice for medicinal products for human use
Tilskipun framkvæmdastjórnarinnar (ESB) 2017/1572 frá 15. september 2017 um viðbætur við tilskipun Evrópuþingsins og ráðsins 2001/83/EB að því er varðar meginreglur og viðmiðunarreglur um góða framleiðsluhætti við gerð mannalyfja
Commission Directive 91/356/EEC of 13 June 1991 laying down the principles and guidelines of good manufacturing practice for medicinal products for human use
Council Directive 90/677/EEC of 13 December 1990 extending the scope of Directive 81/851/EEC on the approximation of the laws of the Member States relating to veterinary medicinal products and laying down additional provisions for immunological veterinary medicinal products
Council Directive 89/343/EEC of 3 May 1989 extending the scope of Directives 65/65/EEC and 75/319/EEC and laying down additional provisions for radiopharmaceuticals
Council Directive 89/342/EEC of 3 May 1989 extending the scope of Directives 65/65/EEC and 75/319/EEC and laying down additional provisions for immunological medicinal products consisting of vaccines, toxins or serums and allergens
Council Directive 87/22/EEC of 22 December 1986 on the approximation of national measures relating to the placing on the market of high-technology medicinal products, particularly those derived from biotechnology
Council Directive 87/20/EEC of 22 December 1986 amending Directive 81/852/EEC on the approximation of the laws of the Member States relating to analytical, pharmaco- toxicological and clinical standards and protocols in respect of the testing of veterinary medicinal products
Council Directive 81/852/EEC of 28 September 1981 on the approximation of the laws of the Member States relating to analytical, pharmaco-toxicological and clinical standards and protocols in respect of the testing of veterinary medicinal products
Council Directive 90/676/EEC Of 13 December 1990 amending Directive 81/851/EEC on the approximation of the laws of the Member States relating to veterinary medicinal products
Council Directive 81/851/EEC of 28 September 1981 on the approximation of the laws of the Member States relating to veterinary medicinal products
Council Directive 78/420/EEC of 2 May 1978 amending Second Directive 75/319/EEC on the approximation of provisions laid down by law, regulation or administrative action relating to proprietary medicinal products
Council Directive 87/19/EEC of 22 December 1986 amending Directive 75/318/EEC on the approximation of the laws of the Member States relating to analytical, pharmaco- toxicological and clinical standards and protocols in respect of the testing of proprietary medicinal products
D044495/01
Commission Directive (EU) 2016/1214 of 25 July 2016 amending Directive 2005/62/EC as regards quality system standards and specifications for blood establishments
Tilskipun framkvæmdastjórnarinnar (ESB) 2016/1214 frá 25. júlí 2016 um breytingu á tilskipun 2005/62/EB að því er varðar staðla og forskriftir fyrir gæðakerfi blóðþjónustustofnana
Council Directive 75/318/EEC of 20 May 1975 on the approximation of the laws of Member States relating to analytical, pharmaco-toxicological and clinical standards and protocols in respect of the testing of proprietary medicinal products
Council Directive 87/21/EEC of 22 December 1986 amending Directive 65/65/EEC on the approximation of provisions laid down by law, regulation or administrative action relating to proprietary medicinal products
Council Directive 83/570/EEC of 26 October 1983 amending Directives 65/65/EEC, 75/318/EEC and 75/319/EEC on the approximation of provisions laid down by law, regulation or administrative action relating to proprietary medicinal products
Second Council Directive 75/319/EEC of 20 May 1975 on the approximation of provisions laid down by Law, Regulation or Administrative Action relating to proprietary medicinal products
Council Directive 65/65/EEC of 26 January 1965 on the approximation of provisions laid down by Law, Regulation or Administrative Action relating to proprietary medicinal products
Council Directive 89/341/EEC of 3 May 1989 amending Directives 65/65/EEC, 75/318/EEC and 75/319/EEC on the approximation of provisions laid down by law, regulation or administrative action relating to proprietary medicinal products
Commission Directive 2014/110/EU of 17 December 2014 amending Directive 2004/33/EC as regards temporary deferral criteria for donors of allogeneic blood donations
Tilskipun framkvæmdastjórnarinnar 2014/110/ESB frá 17. desember 2014 um breytingu á tilskipun 2004/33/EB að því er varðar viðmiðanir fyrir tímabundna frávísun gjafa blóðeininga sem gefa á öðrum
D034433/04
Commission Directive (EU) 2015/566 of 8 April 2015 implementing Directive 2004/23/EC as regards the procedures for verifying the equivalent standards of quality and safety of imported tissues and cells
Tilskipun framkvæmdastjórnarinnar (ESB) 2015/566 frá 8. apríl 2015 um framkvæmd tilskipunar 2004/23/EB að því er varðar verklagsreglur til að sannprófa hvort gæða- og öryggiskröfur varðandi innflutta vefi og frumur eru sambærilegar
D034434/04
Commission Directive (EU) 2015/565 of 8 April 2015 amending Directive 2006/86/EC as regards certain technical requirements for the coding of human tissues and cells
Tilskipun framkvæmdastjórnarinnar (ESB) 2015/565 frá 8. apríl 2015 um breytingu á tilskipun 2006/86/EB að því er varðar tilteknar, tæknilegar kröfur varðandi kóðun vefja og frumna úr mönnum
Commission Directive 2012/39/EU of 26 November 2012 amending Directive 2006/17/EC as regards certain technical requirements for the testing of human tissues and cells
Tilskipun framkvæmdastjórnarinnar 2012/39/ESB frá 26. nóvember 2012 um breytingu á tilskipun 2006/17/EB að því er varðar tilteknar, tæknilegar kröfur varðandi prófanir á vefjum og frumum úr mönnum
Directive 2012/26/EU of the European Parliament and of the Council of 25 October 2012 amending Directive 2001/83/EC as regards pharmacovigilance
Tilskipun Evrópuþingsins og ráðsins 2012/26/ESB frá 25. október 2012 um breytingu á tilskipun 2001/83/EB að því er varðar lyfjagát